9/8/25 16:59 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wan Jerry | A1 | O | Principa | 1 | S.d | -39 | 2.77 | 0 | -14 | | 33 | D | | | | | | | | | | | | | | |
9/8/25 16:54 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Thomas Braxton | WA | D | | 1 | S.d | -387 | 2.77 | 0 | -140 | | 315 | D | | | | | | | | | | | | | | |
9/8/25 16:51 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | P,CMO | 1 | S.d | -77 | 2.77 | 0 | -28 | | 116 | D | | | | | | | | | | | | | | |
9/8/25 16:39 | 9/4/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Xinos Jaime | WA | O | Chief Co | 1 | S.d | -58 | 2.77 | 0 | -21 | | 74 | D | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Patel Rajiv A | CA | H | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Farallon Partners L L C/Ca | CA | TH | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/15/25 16:33 | 8/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S | -164 | 53.57 | 0 | -3 | | 108 | D | | | | | | | | | | | | | | |
8/15/25 16:07 | 8/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | 1 | S | -19 | 24.77 | 0 | -1 | | 35 | D | | | | | | | | | | | | | | |
8/14/25 18:01 | 8/12/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | 1 | S | -264 | 649.79 | 0 | 0 | | 11 | D | | | | | | | | | | | | | | |
8/13/25 17:17 | 8/11/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 2 | S.d | -5,291 | 634.18 | 0 | -8 | | 18 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | 1 | S.d | -3,551 | 651.60 | 0 | -5 | | 6 | D | | | | | | | | | | | | | | |
8/8/25 20:38 | 8/6/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 1 | S.d | -18,492 | 631.98 | 0 | -29 | | 83 | D | | | | | | | | | | | | | | |
8/8/25 20:37 | 8/6/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 1 | S.d | -5,280 | 627.74 | 0 | -8 | | 8 | D | | | | | | | | | | | | | | |
7/25/25 16:05 | 7/23/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dulac Edward J III | MA | O | EVP,CFO | 1 | S | -105 | 14.02 | 0 | -7 | | 106 | D | | | | | | | | | | | | | | |
7/3/25 16:11 | 7/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S | -10 | 9.82 | 0 | -1 | | 95 | D | | | | | | | | | | | | | | |
7/3/25 16:07 | 7/2/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -25 | 9.95 | 0 | -3 | | 57 | D | | | | | | | | | | | | | | |
7/2/25 17:50 | 6/30/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goodman Jesse | MA | D | | 1 | S.m | -29 | 9.40 | 0 | -3 | | 24 | D | | | | | | | | | | | | | | |
7/1/25 16:59 | 6/27/25 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Demski Martha J | CA | D | | 1 | S | -41 | 5.06 | 0 | -8 | | 12 | D | | | | | | | | | | | | | | |